Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Tesini

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Hepatology (Baltimore, Md.)|September 22, 2025
Evolving precision: Updates in targeted therapy for cholangiocarcinomaGiulia Tesini, Halima Ibrahim, Lorenza Rimassa, et al.
Journal of Liver Cancer|August 8, 2024
New systemic treatment options for advanced cholangiocarcinomaValentina Zanuso, Giulia Tesini, Elena Valenzi, et al.
Cancers|January 11, 2025
Learning from Other Tumors: Pathways for Progress and Overcoming Challenges in CholangiocarcinomaGiulia Tesini, Chiara Braconi, Lorenza Rimassa, et al.
Radiation Oncology (London, England)|April 21, 2016
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT techniquePaolo Borghetti, Sara Pedretti, Luigi Spiazzi, et al.
Frontiers in Pharmacology|August 28, 2020
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 PatientsPasquale Paolisso, Luca Bergamaschi, Emanuela Concetta D'Angelo, et al.
Journal of Neuro-Oncology|March 31, 2016
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed?Michela Buglione, Sara Pedretti, Pietro Luigi Poliani, et al.
Infection|April 29, 2022
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort studyMaddalena Giannella, Matteo Rinaldi, Giulia Tesini, et al.
JHEP Reports : Innovation in Hepatology|May 21, 2026
IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancersGiulia Tesini, Jack Greaves, Olivia Knight, et al.
Journal of Hepatology|December 28, 2025
Molecular profiling and matched targeted treatment in cholangiocarcinoma: results from the Italian dataset (ANITA)Virginia Genovesi, Francesca Salani, Margherita Rimini, et al.
Hepatology (Baltimore, Md.)|December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapyBernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|September 22, 2025
Evolving precision: Updates in targeted therapy for cholangiocarcinomaGiulia Tesini, Halima Ibrahim, Lorenza Rimassa, et al.
Journal of Liver Cancer|August 8, 2024
New systemic treatment options for advanced cholangiocarcinomaValentina Zanuso, Giulia Tesini, Elena Valenzi, et al.
Cancers|January 11, 2025
Learning from Other Tumors: Pathways for Progress and Overcoming Challenges in CholangiocarcinomaGiulia Tesini, Chiara Braconi, Lorenza Rimassa, et al.
Radiation Oncology (London, England)|April 21, 2016
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT techniquePaolo Borghetti, Sara Pedretti, Luigi Spiazzi, et al.
Frontiers in Pharmacology|August 28, 2020
Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 PatientsPasquale Paolisso, Luca Bergamaschi, Emanuela Concetta D'Angelo, et al.
Journal of Neuro-Oncology|March 31, 2016
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed?Michela Buglione, Sara Pedretti, Pietro Luigi Poliani, et al.
Infection|April 29, 2022
Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort studyMaddalena Giannella, Matteo Rinaldi, Giulia Tesini, et al.
JHEP Reports : Innovation in Hepatology|May 21, 2026
IDH1 R132 mutations or HER2-positivity and benefit from platinum-based therapy for biliary tract cancersGiulia Tesini, Jack Greaves, Olivia Knight, et al.
Journal of Hepatology|December 28, 2025
Molecular profiling and matched targeted treatment in cholangiocarcinoma: results from the Italian dataset (ANITA)Virginia Genovesi, Francesca Salani, Margherita Rimini, et al.
Hepatology (Baltimore, Md.)|December 7, 2024
Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapyBernhard Scheiner, Beodeul Kang, Lorenz Balcar, et al.
Pageof 2